F01023 – Weight Management Medication Trial
Fusion Clinical Research, Norwood
We are seeking participants in this trial for a new weight management medication.
To be eligible, participants must:
- Have a history of at least one self-reported unsuccessful dietary effort to lose body weight.
AND
a) BMI ≥ 27.0 kg/m2 with the presence of at least one weight-related co-morbidity including, but not limited to, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease.
OR
b) BMI ≥ 30.0 kg/m2.
The study drug will be self-administered via subcutaneous injection.
The duration of the study is approximately 42 weeks.
To register your interest, follow the link below to the registration form.
Eligibility requirements
- Age: 18-75
- Sex: Males and Females (Females must be of non-child bearing potential)
- BMI: BMI ≥ 27.0 kg/m2
- Medical History: History of at least one self-reported unsuccessful dietary effort to lose body weight. a) BMI ≥ 27.0 kg/m2 with the presence of at least one weight-related co-morbidity including, but not limited to, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease. b) BMI ≥ 30.0 kg/m2.
Overnight Stays
- Nil
Payment/Remuneration
- $120 per visit (fasting visits will receive an additional $25 to cover meals)
How to apply
Applications for this study are now closed. Please visit our list of current trials available.